Boothe v. Secretary of Health and Human Services ( 2018 )


Menu:
  •                  In the United States Court of Federal Claims
    OFFICE OF SPECIAL MASTERS
    Filed: September 17, 2018
    * * * * * * * * * *                           *   *    *
    TIMOTHY WERNER BOOTHE,                                 *                 UNPUBLISHED
    *
    Petitioner,                          *                 No. 17-1560V
    *
    v.                                                     *                 Special Master Gowen
    *
    SECRETARY OF HEALTH                                    *                 Ruling on Entitlement; Table Injury;
    AND HUMAN SERVICES,                                    *                 Influenza Vaccine; Guillain-Barré
    *                 Syndrome.
    Respondent.                          *
    *    * *     *    * * * *           *    *    *   *    *
    Robert Oushalem, San Jose, CA, for petitioner.
    Linda S. Renzi, United States Department of Justice, Washington, DC, for respondent.
    RULING ON ENTITLEMENT1
    On October 19, 2017, Timothy Werner Boothe (“petitioner”) filed a petition for
    compensation (“Petition”) under the National Vaccine Injury Compensation Program (“the
    Program”).2 Petitioner alleges that he suffered Guillain-Barré Syndrome (GBS) as a result of
    receiving an influenza (“flu”) vaccination on October 3, 2016. Petition at 1.
    On September 14, 2018, respondent filed a report pursuant to Vaccine Rule 4(c) stating
    that petitioner’s claim was appropriate for compensation. Respondent (“Resp.”) Report (“Rpt.”)
    at 1. Specifically, respondent has concluded that petitioner suffered GBS following a flu vaccine
    within the Table time period, and there is not a preponderance of the medical evidence that
    petitioner’s GBS was due to a factor unrelated to the vaccination. 
    Id. at 4.
    The claim also meets
    the severity requirements because petitioner experienced sequelae of his GBS for more than six
    1
    Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this unpublished ruling
    contains a reasoned explanation for the action in this case, I intend to post it on the website of the United
    States Court of Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7.
    Before the ruling is posted on the court’s website, each party has 14 days to file a motion requesting redaction “of any
    information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is
    privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would
    constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). “An objecting party must provide the
    court with a proposed redacted version” of the ruling. 
    Id. If neither
    party files a motion for redaction within 14
    days, the ruling will be posted on the court’s website without any changes. 
    Id. 2 The
    Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-10 et seq.
    (hereinafter “Vaccine Act” or “the Act”). Hereafter, individual section references will be to 42 U.S.C. § 300aa of the
    Act.
    months. 
    Id. Therefore, based
    on the record as it now stands, compensation is appropriate, as
    petitioner has satisfied all legal prerequisites for compensation under the act. 
    Id. A special
    master may determine whether a petitioner is entitled to compensation based
    upon the record. A hearing is not required. § 300aa-13; Vaccine Rule 8(d). In light of
    respondent’s concession and a review of the record, the undersigned finds that petitioner is
    entitled to compensation. This matter shall now proceed to the damages phase.
    IT IS SO ORDERED.
    s/Thomas L. Gowen
    Thomas L. Gowen
    Special Master
    2
    

Document Info

Docket Number: 17-1560

Judges: Thomas L. Gowen

Filed Date: 10/12/2018

Precedential Status: Non-Precedential

Modified Date: 4/18/2021